| Literature DB >> 26310427 |
Braden S Jensen1, Tobias Willer2, Dimah N Saade1, Mary O Cox3, Tahseen Mozaffar4, Mena Scavina5, Vikki A Stefans6, Thomas L Winder7,8, Kevin P Campbell2, Steven A Moore3, Katherine D Mathews1.
Abstract
Mutations in GDP-mannose pyrophosphorylase B (GMPPB), a catalyst for the formation of the sugar donor GDP-mannose, were recently identified as a cause of muscular dystrophy resulting from abnormal glycosylation of α-dystroglycan. In this series, we report nine unrelated individuals with GMPPB-associated dystroglycanopathy. The most mildly affected subject has normal strength at 25 years, whereas three severely affected children presented in infancy with intellectual disability and epilepsy. Muscle biopsies of all subjects are dystrophic with abnormal immunostaining for glycosylated α-dystroglycan. This cohort, together with previously published cases, allows preliminary genotype-phenotype correlations to be made for the emerging GMPPB common variants c.79G>C (p.D27H) and c.860G>A (p.R287Q). We observe that c.79G>C (p.D27H) is associated with a mild limb-girdle muscular dystrophy phenotype, whereas c.860G>A (p.R287Q) is associated with a relatively severe congenital muscular dystrophy typically involving brain development. Sixty-six percent of GMPPB families to date have one of these common variants.Entities:
Keywords: GMPPB; congenital muscular dystrophy; congenital myasthenic syndrome; dystroglycanopathy; limb-girdle muscular dystrophy
Mesh:
Substances:
Year: 2015 PMID: 26310427 PMCID: PMC4843780 DOI: 10.1002/humu.22898
Source DB: PubMed Journal: Hum Mutat ISSN: 1059-7794 Impact factor: 4.878